02/15/2017 - 1:44pm

Greenlight Capital’s David Einhorn reportedly initiates position with 1.5 million Fred’s Pharmacy shares and ups Rite Aid stake to nearly 20.5 million shares in the fourth quarter.

02/15/2017 - 10:55am

Naloxone is also available for purchase without patient specific prescriptions at Rite Aid pharmacies in 17 additional states.

02/03/2017 - 9:34am

The National Retail Federation estimates the proposed tax on imports could cost American families as much $1,700 per year.

02/01/2017 - 1:49pm

Rite Aid shelves are lined with a large assortment of classic chocolate hearts, among other seasonal delights, for Valentine's Day.

01/31/2017 - 12:35pm

Evercore ISI’s Ross Muken has reiterated his “buy” rating on Walgreens stock.

01/30/2017 - 9:04am

Under the terms of the amendment, Walgreens Boots Alliance will pay a maximum of $7 per share, down from $9 per share, and the end date is extended from Jan. 27 to July 31.

01/27/2017 - 3:39pm

Citing sources close to the negotiations, The New York Post on Friday reported that private-equity giant Cerberus Capital may emerge as a possible white knight for Walgreens and Rite Aid by acquiring the 865 stores being divested. "Cerberus had participated in Walgreen’s December auction of the stores in question, losing to a winning bid of $950 million from regional drug chain Fred’s, according to two sources close to the situation," The Post reported. "Walgreens had rejected Cerberus’ bid partly because it was concerned the Federal Trade Commission would not approve a private-equity buyer, according to the sources." Either way, the deal is "not in danger of collapsing" even though the deal technically expires Friday, The Post added. (The New York Post)

01/26/2017 - 4:19pm

If the Walgreens-Rite Aid deal is not extended, Walgreens may need to forfeit a $325 million termination fee, analysts noted.

01/26/2017 - 10:03am

"At this time, we are actively engaged in discussion with Rite Aid regarding how to proceed," Walgreens Boots Alliance CEO Stefano Pessina told shareholders. "These discussions include taking into account anything that is required to gain approval."